Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study-Reference-Cited by-同舟云学术

Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study

Published:2013-05 Issue:3 Volume:1 Page:199-209
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Wedzicha Jadwiga A,Decramer Marc,Ficker Joachim H,Niewoehner Dennis E,Sandström Thomas,Taylor Angel Fowler,D'Andrea Peter,Arrasate Christie,Chen Hungta,Banerji Donald

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference43 articles.

1. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study;Kanner;Am J Respir Crit Care Med,2001

2. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease;Donaldson;Thorax,2002

3. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease;Soler-Cataluña;Thorax,2005

4. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments);Connors;Am J Respir Crit Care Med,1996

5. Physical activity and hospitalization for exacerbation of COPD;Pitta;Chest,2006

Cited by 438 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in COPD severe exacerbations, and all-cause and respiratory mortality, before and after implementation of newer long-acting bronchodilators in a large population-based cohort;BMC Pulmonary Medicine;2024-09-13

2. National Development in the Use of Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease: Repeated Cross-Sectional Studies from 1998 to 2018;Biomedicines;2024-02-05

3. Factors affecting the outcomes in stable chronic obstructive pulmonary disease patients at an Army Central Hospital;PHARM PRACT-GRANADA;2024

4. Breathlessness and “exacerbation” questions predictive for incident COPD (MARKO study): data after two years of follow-up;PeerJ;2023-12-18

5. Tiotropium bromide in the treatment of chronic obstructive pulmonary disease;PULMONOLOGIYA;2023-12-13